Linus Backert

21 papers receiving 1.6k citations

Linus Backert's Hit Papers

Safety and immunogenicity of a mRNA rabies vaccine in healthy adults: an open-label, non-randomised, prospective, first-in-human phase 1 clinical trial 2017 · 435 citations
4350+3+6Years since publication100200300400

Peers

Linus Backert
Comparison fields: 5 of 69
  • Immunology 522
  • Oncology 290
  • Molecular Biology 809
  • Infectious Diseases 236
  • Virology 37
Replace Niels Emmerich with:
Niels Emmerich Germany
Toshiaki Maruyama United States
Birkir Reynisson Denmark
Annika Nelde Germany
Alessia Covre Italy
Jens Bauer Germany
Petra Simon Germany
Juliane Sarah Walz Germany
Sebastian Lunemann Germany
Björn‐Philipp Kloke Germany
Linus Backert relative to Niels Emmerich Germany Niels Emmerich's profile →
Citations per field
00.5×2×3×4.4×
Niels Emmerich · 1×
Citations per year

Countries citing papers authored by Linus Backert

Since Specialization
Citations

This map shows the geographic impact of Linus Backert's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Linus Backert with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Linus Backert more than expected).

Fields of papers citing papers by Linus Backert

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Linus Backert. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Linus Backert. The network helps show where Linus Backert may publish in the future.

Co-authors

The 25 scholars most cited alongside Linus Backert, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Linus Backert Line = papers co-authored together Linus Backert links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 21 papers — load more, or switch the sort, to bring in the rest.

#Work
1
Safety and immunogenicity of a mRNA rabies vaccine in healthy adults: an open-label, non-randomised, prospective, first-in-human phase 1 clinical trial
Hit paper breakdown →
2017435
2 2021173
3 2015168
4 2017139
5 2014136
6 2017102
7 201587
8 201780
9 201954
10 201843
11 201840
12 202039
13 201733
14 201620
15 201618
16 201617
17 201715
18 201712
19 20148
20 20185

About Linus Backert

Linus Backert is a scholar working on Immunology, Genetics, Molecular Biology, Hematology and Oncology, having authored 21 papers that have together received 1.6k indexed citations. Recurring topics across this work include vaccines and immunoinformatics approaches (12 papers), Immunotherapy and Immune Responses (9 papers), Chronic Lymphocytic Leukemia Research (4 papers), Cancer Immunotherapy and Biomarkers (4 papers), Multiple Myeloma Research and Treatments (2 papers), Rabies epidemiology and control (1 paper), Gene expression and cancer classification (1 paper) and Acute Myeloid Leukemia Research (1 paper). The work is most often cited by research in Immunology (522 citations), Oncology (290 citations), Molecular Biology (809 citations), Infectious Diseases (236 citations) and Virology (37 citations). Linus Backert has collaborated with scholars based in Germany, Switzerland and United States. Frequent co-authors include Oliver Kohlbacher, Hans‐Georg Rammensee, Stefan Stevanović, Heiko Schuster, Ulrike Gnad-Vogt, Ingmar Hoerr, Mariola Fotin‐Mleczek, Sven Dominik Koch, Henoch Sangjoon Hong and Mihai Alexandru Bica. Their work appears in journals such as Blood, OncoImmunology, Genome Medicine, Journal for ImmunoTherapy of Cancer and Proceedings of the National Academy of Sciences.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact